小动脉瘤大小 (<10毫米) 预测流量转移后的完全闭塞吗? 一个超越进化单中心研究
Gaurav Gupta1, Sanjeev Sreenivasan1, Seung Woo Baek1
1Department of Neurosurgery, Robert Wood Johnson University Hospital, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
概括
在治疗内动脉瘤方面,Surpass Evolve流量转移器 (SEFD) 证明了良好的长期安全性和有效性. 较小的动脉瘤大小 (<10毫米) 预测了成功的闭塞,并发症率低.
科学领域:
- 神经外科 神经外科
- 干预性神经辐射学
- 医疗器械 医疗器械
背景情况:
- 在治疗内动脉瘤时,Surpass Evolve流量转移器 (SEFD) 的长期安全性和有效性数据有限.
- 影响SEFD完全动脉瘤封闭的因素在现有文献中尚不清楚.
研究的目的:
- 评估Surpass Evolve流量转移器 (SEFD) 的长期安全性和有效性.
- 为了确定SEFD治疗后完全动脉瘤封闭的预测因素.
主要方法:
- 在2020年2月至2022年7月期间使用SEFD治疗的80个内动脉瘤的回顾性审查.
- 分析技术成功率,6个月,1年,2年后的闭塞率和并发症率.
主要成果:
- 在SEFD部署方面,技术成功率为100%.
- 六个月封闭率为56.2%,在两年内增加到88.8%.
- 动脉瘤大小<10毫米显著预测了6个月的闭塞 (OR:2.16).
- 没有死亡率或永久的神经疾病;主要并发症发生在7.2%.
结论:
- 在内动脉瘤方面,SEFD提供了有利的长期安全性和有效性.
- 较小的动脉瘤大小 (<10毫米) 与在6个月成功封闭有关.
- 该设备显示,它有望在神经血管干预中得到更广泛的采用.
相关概念视频
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...